Matthew Shea
Stock Analyst at Needham
(3.70)
# 2,117
Out of 4,675 analysts
42
Total ratings
60.7%
Success rate
14.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matthew Shea
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASTH Astrana Health | Reiterated: Buy | $41 | $38.11 | +7.58% | 4 | Aug 7, 2026 | |
| STLN Starling Oncology | Reiterated: Buy | $7 | $6.13 | +14.19% | 10 | Aug 7, 2026 | |
| EVH Evolent Health | Reiterated: Buy | $5 | $4.72 | +5.93% | 12 | Aug 6, 2026 | |
| AGL agilon health | Reiterated: Hold | n/a | $93.79 | - | 9 | Aug 6, 2026 | |
| PRVA Privia Health Group | Reiterated: Buy | $30 | $21.02 | +42.72% | 7 | May 7, 2026 |
Astrana Health
Aug 7, 2026
Reiterated: Buy
Price Target: $41
Current: $38.11
Upside: +7.58%
Starling Oncology
Aug 7, 2026
Reiterated: Buy
Price Target: $7
Current: $6.13
Upside: +14.19%
Evolent Health
Aug 6, 2026
Reiterated: Buy
Price Target: $5
Current: $4.72
Upside: +5.93%
agilon health
Aug 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $93.79
Upside: -
Privia Health Group
May 7, 2026
Reiterated: Buy
Price Target: $30
Current: $21.02
Upside: +42.72%